Spero Therapeutics
Industry: Company
DescriptionHeadquarters: Massachusetts Founded: 2013 Subsidiaries: Spero Potentiator, Inc,
Spero Therapeutics List of Employees There's an exhaustive list of past and present employees! Get comprehensive information on the number of employees at Spero Therapeutics. You can filter them based on skills, years of employment, job, education, department, and prior employment.
Spero Therapeutics Salaries. You can even request information on how much does Spero Therapeutics pay if you want to. Learn about salaries, pros and cons of working for Spero Therapeutics directly from the past employees.
Find People by Employers You can rekindle an old relationship, reconnect with a long-lost friend, former boss, business acquaintance who might be useful in your new line of work. With our employee database, the possibilities are endless. All you have to do is type in a couple of keywords and we'll bring you the exact information you wanted!
11 Spero Therapeutics employees in database. Find out everything there's to know about Spero Therapeutics employees. We offer you a great deal of unbiased information from the internal database, personal records, and many other details that might be of interest to you.
Spero Therapeutics Employees
Spero Therapeutics April 2013 - Present
Harvard Medical School 1998 - Present
Massachusetts General Hospital January 1997 - Present
Skills
Microbiology, Molecular Genetics, Molecular Biology, Infectious Diseases, Research, Sequence Analysis, Bioinformatics, Transcriptomics, Immunology, Cell Biology, Lifesciences, Chemistry, Cell, Genetics, Laboratory
Education
University of California, Berkeley 1987 — 1991
Doctor of Philosophy (Ph.D.)
University of Naples, Institute of Genetics and Biophysics C.N.R., Naples, Italy 1984 — 1985
Master's degree, Molecular Genetics
University of Naples, Italy 1980 — 1984
Bachelor's degree, Biological and Biomedical Sciences
Spero Therapeutics May 2014 - Present
Fedora Pharmaceuticals March 2012 - May 2014
Nimbus Discovery July 2010 - May 2012
Targanta Therapeutics January 2005 - January 2010
Adaptive Therapeutics 2003 - 2004
Eli Lilly and Company 1987 - 2000
Skills
Infectious Diseases, Microbiology, Pharmaceuticals, Pharmaceutical Industry, In Vitro, In Vivo, Drug Development, Biotechnology, Clinical Development, Drug Discovery, Biochemistry, Animal Models, Technology Transfer, FDA, Commercialization, Lifesciences, Cell Culture, Pharmacokinetics, Genomics, Clinical Research, Assay Development, Immunology, Biopharmaceuticals, Oncology, Biomarkers, Pharmacology, Antibodies, Vaccines, IND, Clinical Trials, GLP, Life Sciences, Monoclonal Antibodies
Education
University of Calgary 1980 — 1984
Ph.D., Medical Microbiology
Merck January 2015 - Present
Massachusetts General Hospital July 2015 - Present
Brigham and Women's Hospital 2006 - Present
RaNA Therapeutics July 2015 - Present
Spero Therapeutics June 2015 - Present
Visterra Inc. February 2015 - Present
Harvard Medical School 2006 - Present
Surface Oncology February 2014 - January 2015
Ataxion, Inc July 2013 - January 2015
Atlas Venture October 2012 - January 2015
Skills
Lifesciences, Healthcare Information..., Healthcare, Biotechnology, Venture Capital, Medical Devices, Emergency Medicine, Business Strategy, Start-ups, Pharmaceutical Industry, Life Sciences, Oncology, Strategy, Hospitals, Due Diligence, Medicine, Entrepreneurship, Drug Discovery, Clinical Research, Clinical Trials, Mergers & Acquisitions
Education
University of Pennsylvania - The Wharton School 2000 — 2002
MBA
University of Pennsylvania School of Medicine 1997 — 2002
MD
Williams College 1992 — 1996
BA
Collegiate School 1980 — 1992
Spero Therapeutics April 2015 - Present
Spero Therapeutics February 2014 - April 2015
Achillion Pharmaceuticals 2001 - 2014
Bristol-Myers Squibb 1988 - 2001
Microlife Techincs 1986 - 1988
Virginia Commonwelath University 1983 - 1986
Skills
Drug Discovery, Microbiology, Pharmaceutical Industry, Genomics, Biotechnology, Infectious Diseases, Molecular Biology
Education
St. Thomas Aquinas High School
Temple University School of Medicine
Ph.D., Microbiology
University of Connecticut
B.S., Biology
Spero Therapeutics July 2015 - Present
Epizyme August 2012 - June 2015
Biogen Idec January 2011 - July 2012
Biogen Idec 2008 - 2010
Biogen Idec February 2005 - July 2008
Kraft Foods 1998 - 2005
Kraft Foods Poland 1996 - 1998
Kraft Foods Europe 1994 - 1996
Kraft Foods Europe 1992 - 1994
Kraft Foods Germany 1989 - 1992
Skills
IPO, Due Diligence, Mergers & Acquisitions, Financial Reporting, Biotechnology, Finance, Management, Mergers, Strategic Financial..., Treasury, Internal Controls, International, M&A experience, Divestitures, Supply Chain, Manufacturing, Lifesciences, Consumer Products, Financial Analysis, Corporate Finance, Sarbanes-Oxley Act, Analysis, Strategy, US GAAP, Financial Controlling, Financial Modeling, Life Sciences
Education
New York University - Leonard N. Stern School of Business 1984 — 1986
MBA, Finance
George Mason University 1978 — 1981
BS, Economics
Spero Therapeutics September 2015 - Present
Novartis Institutes for BioMedical Research (NIBR) September 2009 - September 2015
Northwestern University March 2007 - September 2009
State University of New York at Buffalo January 2002 - March 2007
Skills
NMR, Medicinal Chemistry, Mass Spectrometry, UV/Vis, LC-MS, Purification, Synthetic Organic..., Characterization, Chemistry, Drug Discovery, Organic Chemistry, Organic Synthesis, HPLC, Chromatography, Analytical Chemistry, Spectroscopy, Research, Life Sciences, Drug Design, Biotechnology
Education
University at Buffalo 2002 — 2007
Ph. D., Organic Chemistry, Chemler Lab
Canisius College 1997 — 2001
BS, Chemistry
Spero Therapeutics September 2014 - Present
AstraZeneca December 2012 - September 2014
Novartis Institutes for BioMedical Research March 2008 - December 2012
The Scripps Research Institute January 2006 - January 2008
Skills
Medicinal Chemistry, Drug Discovery, Organic Synthesis, Drug Design, NMR, Infectious Diseases, Drug Development, Organic Chemistry, Lead Change, Synthetic Organic..., Chemistry, Virology, Bacteriology, Pharmacology, Team Leadership, HCV, LC-MS, HPLC, Computational Chemistry, Lifesciences, Purification
Education
Flinders University 2003 — 2006
Ph.D, Chemistry
Health Catalyst May 2013 - Present
Spero Therapeutics August 2015 - Present
Adheron Therapeutics, Inc. March 2008 - Present
Boston Biomedical Innovation Center September 2013 - Present
Visionscope March 2009 - Present
Mass Medical Angels November 2008 - Present
Provasculon, Inc March 2008 - Present
Innovation Fund, Partners HealthCare February 2007 - Present
Daktari Diagnostics August 2009 - February 2015
CoStim Pharmaceuticals August 2012 - February 2014
Education
Columbia University - Columbia Business School 1992 — 1994
MBA, Finance and Business Development
Harvard University 1985 — 1989
AB
Spero Therapeutics May 2015 - Present
Cubist Pharmaceuticals November 2011 - May 2015
Cubist Pharmaceuticals January 2011 - November 2011
Cubist Pharmaceuticals July 2007 - December 2010
Cubist Pharmaceuticals November 2005 - June 2007
Dow Chemical January 2005 - November 2005
Education
University of California, San Diego 2001 — 2004
Postdoctoral research, Microbiology, General
University of Wisconsin-Madison 1994 — 2000
PhD Bacteriology, Medical Microbiology and Bacteriology
University of Illinois at Urbana-Champaign 1989 — 1994
BS, Microbiology and Chemistry
Spero Therapeutics August 2015 - Present
AstraZeneca R&D June 1999 - May 2015
Genetics Institute July 1994 - June 1999
Skills
Animal Models, In Vivo, Drug Discovery, Pharmacokinetics, Pharmacology, Drug Development, Lifesciences, Pharmaceutical Research, Pharmacodynamics, Toxicology, Biomarkers, Biomarker Discovery, IACUC, ADME, LC-MS, Compliance, Life Sciences, Biotechnology, GLP, In Vitro, Pharmaceutical Industry, Assay Development
Education
Becker College 1993 — 1994
Associate’s Degree, Veterinary Technology
Fitchburg State University
Business Administration and Management, Biology